-transparent.png){kind=logo}
Amdinocillin is a semisynthetic derivative of 6-beta-amidinopenicillanic acid, which has bactericidal activity against a broad spectrum of gram-negative bacteria. We report the results of a multicenter study evaluating the safety and efficacy of amdinocillin in combination with other beta-lactam antibiotics in the treatment of 120 serious gram-negative bacterial infections. Amdinocillin was safe and well tolerated and, in combination with other beta-lactam antibiotics, was effective in the treatment of a broad range of gram-negative bacterial infections. Therapy with amdinocillin and other beta-lactam antibiotics was often associated with a demonstrable synergistic effect. Thus, amdinocillin holds promise as an effective antibiotic with synergistic potential when used in combination with penicillins and cephalosporins.
J W King, and
T R Beam, and
H C Neu, and
L G Smith
August 1983,
The American journal of medicine,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
January 1988,
Chemotherapy,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
February 1988,
Diagnostic microbiology and infectious disease,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
January 1984,
Antimicrobial agents and chemotherapy,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
August 1983,
The American journal of medicine,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
January 1985,
Drugs,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
September 1983,
The Journal of antimicrobial chemotherapy,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
April 1984,
The Journal of antimicrobial chemotherapy,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
August 1983,
The American journal of medicine,
J W King, and
T R Beam, and
H C Neu, and
L G Smith
December 1980,
Antimicrobial agents and chemotherapy,
